Sales & Marketing
Being loud
Oliver Stohlmann’s Corporate Survival Hacks series draws on experiences of working in local, regional, and global life sciences communications to offer some little tips for enjoying a big b
News
Amid BIOSECURE Act speculation, WuXi AppTec sells unit
WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum
News
FDA approves flurry of drugs ahead of holiday season
The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
News
AZ gets EU okay for Tagrisso in early-stage lung cancer
AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in the class to be approved in the EU for a form of early-stage lung cancer.
News
PBM reform dropped in Congress' funding package
Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
